Product Description
Intracellular Staining Permeabilization Wash Buffer is useful for intracellular staining procedures, e.g. , in preparation of cells for staining intracellular cytokines or other proteins. Intracellular Staining Permeabilization Wash Buffer is used to permeabilize cells following fixation with Intracellular Staining Fixation Buffer (Cat. No. 420801). It is supplied as a 10X solution and should be diluted in deionized water prior to use. Intracellular Staining Permeabilization Wash Buffer has been formulated to have minimal effects on cells, reduce non-specific staining and enhance the signal to noise ratio. It can be used for antibody dilutions and cell washing during intracellular staining.
100ml
Storage & Handling: The Intracellular Staining Perm wash buffer solution should be stored between 2°C and 8°C. Do not freeze.
Application: ICC, ICFC - Quality tested IHC - Reported in the literature, not verified in house
Recommended Usage: For use in permeabilization, dilute Intracellular Staining Permeabilization Wash Buffer (10X) to 1X in DI water. Resuspend fixed cells in diluted Intracellular Staining Permeabilization Wash Buffer and centrifuge at 350 xg for 5-10 minutes, and repeat the process twice. It is recommended that the reagent be titrated for optimal performance for each application. Please see "Intracellular Cytokine Staining Protocol" on BioLegend's website for more details.
Application Notes: The Intracellular Staining Permeabilization Wash Buffer (10X) may have crystallization or precipitation observed when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is heavy precipitation observed after dilution to 1X working solution, the buffer can be filtered to clarify the solution.
Application References(PubMed link indicates BioLegend citation): Smeltz RB. 2007. J. Immunol. 178:4786. Kang YJ, et al. 2007. Nature Immunol. 8:601. del Rio ML, et al. 2011. Transplantation. 92:1085. PubMed del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
Product Citations: Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed Kim S, et al. 2020. Development. 147:00:00. PubMed Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed Rappazzo CG, et al. 2020. bioRxiv. . PubMed Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed Deák P, et al. 2022. Cell Rep. 41:111563. PubMed Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed Deng G, et al. 2023. Cancers (Basel). 15:. PubMed Wang Y, et al. 2023. iScience. 26:106630. PubMed Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed Kim J, et al. 2021. Cytometry A. 99:807. PubMed Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed Nozaki K, et al. 2022. Nature. 606:960. PubMed Shemesh A, et al. 2022. J Exp Med. 219: . PubMed Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed Blanas A, et al. 2022. iScience. 25:104719. PubMed Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed Liang Y, et al. 2022. Theranostics. 12:7729. PubMed Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed Chan L, et al. 2022. Cells. 12: . PubMed Ding D, et al. 2023. J Med Chem. 66:1467. PubMed Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed Sun L, et al. 2023. Mol Med Rep. 27: . PubMed Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed Guo H, et al. 2022. Biomaterials. 283:121441. PubMed Zhang H, et al. 2022. J Exp Med. 219:. PubMed Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed Kusner L, et al. 2014. PLoS One. 9:102231. PubMed Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed Spitzer SO, et al. 2019. Neuron. 101:459. PubMed Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed Li Q, et al. 2022. Cell Rep. 40:111308. PubMed van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed Zhang L, et al. 2021. J Immunol. 207:590. PubMed Li X, et al. 2022. Nat Commun. 13:2794. PubMed Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed Stewart CA, et al. 2020. bioRxiv. . PubMed Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed Angiari S, et al. 2020. Cell Metab. 31:391. PubMed Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed Kiritsy MC, et al. 2021. Elife. 10:. PubMed Poli V, et al. 2021. iScience. 24:103256. PubMed Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed Haryadi L, et al. 2019. Vet World. 12:1529. PubMed Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed Zhou H, et al. 2022. J Clin Invest. 132:. PubMed Zhang X, et al. 2020. J Immunol. 205:1743. PubMed Ni P, et al. 2014. J Immunol . 193:1778. PubMed Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed Su W, et al. 2022. Front Immunol. 13:952338. PubMed Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed Zhan Y, et al. 2021. JCI Insight. 6:. PubMed Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed Zhang X, et al. 2022. Theranostics. 12:1621. PubMed Berical A, et al. 2022. Nat Commun. 13:4270. PubMed Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed Chakraborty S, et al. 2022. Sci Transl Med. . PubMed Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed Lownik JC, et al. 2019. J Immunol. 202:664. PubMed Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed Wei W, et al. 2022. mSystems. 7:e0046922. PubMed Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed Yang J, et al. 2022. Microbiome. 10:149. PubMed Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed Page N, et al. 2021. Nat Commun. 12:1009. PubMed Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed Liu X, et al. 2016. Sci Rep. 6:36722. PubMed Rio M, et al. 2012. J Immunol. 188:4885. PubMed Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed Janela B, et al. 2019. Immunity. 50:1069. PubMed Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed Hayes D, et al. 2022. JCI Insight. 7:. PubMed Gong C, et al. 2021. Mol Cell. 81:4059. PubMed Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed Kim S, et al. 2020. Development. . PubMed Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed Rio M, et al. 2011. Transplantation. 92:1085. PubMed Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed Ma K, et al. 2022. iScience. 25:104347. PubMed Wang Y, et al. 2020. Virol Sin. 36:122. PubMed Lau H, et al. 2020. Islets. 41:12. PubMed Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed Shemesh A, et al. 2022. J Exp Med. 219:. PubMed Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed Park SR, et al. 2020. Cell Rep. 32:108077. PubMed Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed Xia Y, et al. 2018. Cell. 175:1059. PubMed Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed Zhao X, et al. 2022. iScience. 25:104690. PubMed Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed Gao J, et al. 2022. Front Immunol. 13:955812. PubMed Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed Labi V, et al. 2019. Genes Dev. 33:1673. PubMed Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed Huang T, et al. 2022. Nat Commun. 13:3489. PubMed Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed Lee G, et al. 2021. Viruses. 13: . PubMed Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed Su Y, et al. 2020. Cell. 1479:183. PubMed Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed Wagner AK, et al. 2022. iScience. 25:105137. PubMed Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed Witt G, et al. 2020. Cell Biol Toxicol. . PubMed Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed Giadone RM, et al. 2018. Amyloid. 25:148. PubMed Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed Sun Y, et al. 2022. iScience. 25:104846. PubMed van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed Wang X, et al. 2022. Elife. 11:. PubMed Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
Antigen References: 1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD). 2. Sander B, et al. 1991. Immunol. Rev. 119:65. 3. Sander B, et al. 1993. J. Immunol. Meth. 166:201. 4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.
Gene ID: NA
Regulatory Status: RUO
Other Names: Perm/Wash, Permeabilization Buffer
Order Guidelines
1. Price & Stock Available on Request. Click to send email to: service@iright.com
2. Please DO NOT make payment before confirmation.
3. Minimum order value of $1,000 USD required.
Collaboration
Tony Tang
Email: Tony.Tang@iright.com
Mobile/WhatsApp/Wechat: +86-17717886924